The EAIR of herpes zoster was the highest in the TNF-α inhibitor group (17.0 per 1000 PY), followed by the IL-17, IL-23, and IL-12/23 inhibitors (13.3, 7.8, and 2.7 per 1000 PY, respectively). This evidence concerns the gene IL17A and herpes zoster.